More than half of patients with tardive dyskinesia see symptom remission with valbenazine

More than half of patients with tardive dyskinesia who used valbenazine experienced symptomatic remission at 48 weeks, and nearly all of them had meaningful response, according to data presented at Psych Congress Elevate in Las Vegas.Symptom measurements began to return to baseline totals after treatment was halted, Dawn Vanderhoef, PhD, director of medical affairs, psychiatry at Neurocrine